ECO Animal Health Group (LON:EAH) Sets New 52-Week High – What’s Next?

ECO Animal Health Group plc (LON:EAH)’s share price reached a new 52-week high during mid-day trading on Monday . The stock traded as high as GBX 103 and last traded at GBX 99.50, with a volume of 365987 shares. The stock had previously closed at GBX 96.

Analysts Set New Price Targets

Separately, Shore Capital reaffirmed a “buy” rating and set a GBX 150 price target on shares of ECO Animal Health Group in a research note on Monday, November 10th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat, ECO Animal Health Group has a consensus rating of “Buy” and an average target price of GBX 150.

ECO Animal Health Group Stock Performance

The firm has a market cap of £67.15 million, a PE ratio of 40.95 and a beta of -0.05. The business has a 50 day simple moving average of GBX 88.79 and a two-hundred day simple moving average of GBX 75.74. The company has a quick ratio of 2.14, a current ratio of 2.96 and a debt-to-equity ratio of 4.81.

ECO Animal Health Group (LON:EAH) last issued its earnings results on Monday, December 1st. The company reported GBX (0.54) earnings per share (EPS) for the quarter. ECO Animal Health Group had a net margin of 1.17% and a return on equity of 1.27%.

About ECO Animal Health Group

ECO Animal Health is a world leader in animal health, developing and marketing branded veterinary pharmaceuticals globally, with expertise in antibiotics and vaccines for pigs and poultry. We have a maturing proprietary R&D pipeline.

Headquartered in the UK, with global offices including R&D and manufacturing, we have marketing authorisations in over 70 countries and employ over 200 people worldwide.

Our lead product, Aivlosin® is a proprietary, patented medication which is effective against both respiratory and intestinal diseases in pigs and poultry.